EDITORIAL
Published on 06 Dec 2021
Editorial: Immunology and Immunotherapy of Head and Neck Cancer
doi 10.3389/fonc.2021.815763
- 1,061 views
- Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immunology and Immunotherapy of Head and Neck Cancer
Immunology and Immunotherapy of Head and Neck Cancer
23k
Total downloads
77k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 19 Oct 2021
Tumor-Infiltrating Immune-Related Long Non-Coding RNAs Indicate Prognoses and Response to PD-1 Blockade in Head and Neck Squamous Cell Carcinoma
doi 10.3389/fimmu.2021.692079
- 2,446 views
- 8 citations
REVIEW
Published on 21 Sep 2021
Defining the Role of Immunotherapy in the Curative Treatment of Locoregionally Advanced Head and Neck Cancer: Promises, Challenges, and Opportunities
doi 10.3389/fonc.2021.738626
- 2,762 views
- 15 citations
ORIGINAL RESEARCH
Published on 06 Sep 2021
PD-L1-Mediated Immunosuppression in Oral Squamous Cell Carcinoma: Relationship With Macrophage Infiltration and Epithelial to Mesenchymal Transition Markers
doi 10.3389/fimmu.2021.693881
- 4,259 views
- 26 citations
REVIEW
Published on 06 Sep 2021
Immunotherapy for Head and Neck Cancer: A Paradigm Shift From Induction Chemotherapy to Neoadjuvant Immunotherapy
doi 10.3389/fonc.2021.727433
- 21,669 views
- 69 citations
ORIGINAL RESEARCH
Published on 06 Sep 2021
The Immune Landscape of Chinese Head and Neck Adenoid Cystic Carcinoma and Clinical Implication
doi 10.3389/fimmu.2021.618367
- 5,972 views
- 17 citations
REVIEW
Published on 01 Sep 2021
Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
doi 10.3389/fonc.2021.705614
- 5,684 views
- 23 citations
CASE REPORT
Published on 21 Jul 2021
Immunotherapy-Based Therapeutic Strategies for Recurrent Advanced Squamous Cell Carcinoma of the Head and Neck: A Case Report and Literature Review
doi 10.3389/fimmu.2021.680327
- 2,058 views
- 2 citations
ORIGINAL RESEARCH
Published on 29 Jun 2021
EVA1C Is a Potential Prognostic Biomarker and Correlated With Immune Infiltration Levels in WHO Grade II/III Glioma
doi 10.3389/fimmu.2021.683572
- 2,698 views
- 22 citations
CASE REPORT
Published on 27 May 2021
Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient
doi 10.3389/fimmu.2021.678028
- 3,454 views
- 8 citations
ORIGINAL RESEARCH
Published on 07 May 2021
Combination of Immunotherapy and Radiotherapy for Recurrent Malignant Gliomas: Results From a Prospective Study
doi 10.3389/fimmu.2021.632547
- 3,582 views
- 23 citations
ORIGINAL RESEARCH
Published on 05 May 2021
IL-21 Is an Accomplice of PD-L1 in the Induction of PD-1-Dependent Treg Generation in Head and Neck Cancer
doi 10.3389/fonc.2021.648293
- 2,788 views
- 12 citations
Published in
Frontiers in Oncology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Immunology
- 5.7 impact factor
- 9.8 citescore
Impact
- 77kTopic views
- 53kArticle views
- 23kArticle downloads